Hepatocellular carcinoma after Fontan surgery: A systematic review

被引:27
作者
Rodriguez De Santiago, Enrique [1 ]
Tellez, Luis [1 ]
Guerrero, Antonio [1 ]
Albillos, Agustin [1 ]
机构
[1] Univ Alcala, Ramon y Cajal Hlth Res Inst IRYCIS, Dept Gastroenterol & Hepatol, Ramon y Cajal Univ Hosp, Madrid, Spain
关键词
cancer diagnosis; cirrhosis; Fontan surgery; hepatocellular carcinoma; liver; MAGNETIC-RESONANCE ELASTOGRAPHY; CARDIAC CIRRHOSIS; LIVER-DISEASE; PATIENT; RESECTION; HEPATECTOMY; MANAGEMENT; PATHOLOGY; FEATURES; RISK;
D O I
10.1111/hepr.13582
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim Fontan surgery is often the procedure of choice for patients with congenital single effective ventricle. In the long term, elevated systemic venous pressure and chronic ischemia following this procedure could lead to advanced chronic liver disease and there is also a risk of hepatocellular carcinoma (HCC). This review systematically summarizes the characteristics and outcomes of this rare condition. Methods PubMed and Embase databases were searched from inception to January 2020 for studies reporting on HCC after Fontan surgery. The factors analyzed were clinical presentation, histology, imaging findings, treatments, and survival. Our primary analysis was based on biopsy-proven HCC. Results The records selected were 26 observational studies (19 case reports/case series and seven cohort studies) including 65 biopsy-proven HCC. Age at the time of HCC diagnosis ranged from 12 to 52 years, and 62% of the patients were female. Only one case occurred earlier than 10 years after Fontan surgery. Twenty patients had no imaging or histological evidence of liver cirrhosis and 78.3% had elevated alpha-fetoprotein levels. Advanced stage was the most common at diagnosis. The most frequent treatments were transarterial chemoembolization (n = 18) and surgery (n = 12). One-year survival was 50% and only four patients (6.2%) were under liver imaging surveillance. We also analyzed 17 patients with non-biopsy-proven HCC. Conclusions After Fontan surgery, HCC usually occurs at least 10 years later and can develop in the absence of cirrhosis. Biopsy is mandatory to confirm the diagnosis. Patients were diagnosed at a late stage and survival outcomes were poor, highlighting a need for liver surveillance.
引用
收藏
页码:116 / 134
页数:19
相关论文
共 45 条
  • [1] National trends in Fontan operation and in-hospital outcomes in the USA
    Akintoye, Emmanuel
    Miranda, William R.
    Veldtman, Gruschen R.
    Connolly, Heidi M.
    Egbe, Alexander C.
    [J]. HEART, 2019, 105 (09) : 708 - 714
  • [2] Laparoscopic liver resection for hepatocellular carcinoma in Fontan-associated chronic liver disease. The first case report
    Angelico, Roberta
    Lisignoli, Veronica
    Monti, Lidia
    Pariante, Rosanna
    Grimaldi, Chiara
    Saffioti, Maria Cristina
    Gagliardi, Maria Giulia
    Spada, Marco
    [J]. INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2019, 59 : 144 - 147
  • [3] Hepatocellular Carcinoma after the Fontan Procedure
    Asrani, Sumeet K.
    Warnes, Carole A.
    Kamath, Patrick S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (18) : 1756 - 1757
  • [4] Hepatocellular carcinoma in the adult Fontan patient
    Conroy, Michael R.
    Moe, Tabitha G.
    [J]. CARDIOLOGY IN THE YOUNG, 2017, 27 (02) : 407 - 409
  • [5] Fontan-Associated Liver Disease Proceedings from the American College of Cardiology Stakeholders Meeting, October 1 to 2, 2015, Washington DC
    Daniels, Curt J.
    Bradley, Elisa A.
    Landzberg, Mike J.
    Aboulhosn, Jamil
    Beekman, Robert H., III
    Book, Wendy
    Gurvitz, Michelle
    John, Anitha
    John, Binu
    Marelli, Ariane
    Marino, Bradley S.
    Minich, L. Luann
    Poterucha, John J.
    Rand, Elizabeth B.
    Veldtman, Gruschen R.
    Daniels, Curt J.
    Landzberg, Michael J.
    Aboulhosn, Jamil
    Beekman, Robert H., III
    Book, Wendy
    Veldtman, Gruschen R.
    Bradley, Elisa A.
    Carson, Dori
    Cook, Stephen
    Deutch, Jason
    Farr, MaryJane
    Gurvitz, Michelle
    Hickam, David
    Jaquiss, Robert
    Jenkins, Kathy
    John, Anitha
    John, Binu
    Leezer, Scott
    Lemacks, Jodi
    Marelli, Ariane
    Marino, Bradley S.
    Minich, L. Luann
    Pearson, Gail
    Poterucha, John J.
    Rand, Elizabeth B.
    Sherker, Averell H.
    Steury, Rachel
    Tringali, Glenn R.
    Venick, Robert
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (25) : 3173 - 3194
  • [6] Conflicting Hemodynamic Goals in an Adult Patient With Fontan Physiology Presenting for Resection of a Hepatocellular Carcinoma
    Dorsey, David
    Kwon, Steve
    Krieger, Eric
    Yeung, Raymond S.
    Natrajan, Krishna
    Dembo, Gregory
    [J]. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2016, 30 (02) : 452 - 454
  • [7] Long-term survival after the Fontan operation: Twenty years of experience at a single center
    Downing, Tacy E.
    Allen, Kiona Y.
    Glatz, Andrew C.
    Rogers, Lindsay S.
    Ravishankar, Chitra
    Rychik, Jack
    Faerber, Jennifer A.
    Fuller, Stephanie
    Montenegro, Lisa M.
    Steven, James M.
    Spray, Thomas L.
    Nicolson, Susan C.
    Gaynor, J. William
    Goldberg, David J.
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 154 (01) : 243 - +
  • [8] Hepatocellular Carcinoma After Fontan Operation: Multicenter Case Series
    Egbe, Alexander C.
    Poterucha, Joseph T.
    Warnes, Carole A.
    Connolly, Heidi M.
    Baskar, Shankar
    Ginde, Salil
    Clift, Paul
    Kogon, Brian
    Book, Wendy M.
    Walker, Niki
    Wagenaar, Lodewijk
    Moe, Tabitha
    Oechslin, Erwin
    Kay, W. Aaron
    Norris, Mark
    Gordon-Walker, Timothy
    Dillman, Jonathan R.
    Trout, Andrew
    Anwar, Nadeem
    Hoskoppal, Arvind
    Veldtman, Gruschen R.
    [J]. CIRCULATION, 2018, 138 (07) : 746 - 748
  • [9] Features of portal hypertension are associated with major adverse events in Fontan patients: The VAST study
    Elder, Robert W.
    McCabe, Nancy M.
    Hebson, Camden
    Veledar, Emir
    Romero, Rene
    Ford, Ryan M.
    Mahle, William T.
    Kogon, Brian E.
    Sahu, Anurag
    Jokhadar, Maan
    McConnell, Michael E.
    Book, Wendy M.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (04) : 3764 - 3769
  • [10] More on Hepatocellular Carcinoma after the Fontan Procedure
    Elder, Robert W.
    Parekh, Samir
    Book, Wendy M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (05) : 490 - 490